The Government has issued directions to the States and Central Government Health Scheme (CGHS) to accept supply of Ayurveda, Siddha, Unani And Homoeopathy (ASU&H) medicines with batch wise quality analysis from an approved laboratory/NABL accredited Laboratory.
Good Manufacturing Practices for Ayurveda, Siddha and Unani (ASU) drugs has been made mandatory for license of ASU drugs to ensure storage conditions should be free from fungal or bacterial contamination. In-house quality control section is also made mandatory for batch wise testing facility of ASU products.
The Government of India has defined adulterated drugs under section 33 EE (Chapter IV-A) of the Drugs & Cosmetics Act, 1940.
Under Section 33-I, penalties have been prescribed, for manufacture, sale etc. of Ayurvedic, Siddha or Unani drug in contravention of the Act. State Drug Licensing Authorities are empowered to take action accordingly.
HANOI, Vietnam--(BUSINESS WIRE)--#FPT--FPT Software, a leading global technology company, has been listed in the Gartner…
BANGKOK--(BUSINESS WIRE)--International insurance brokerage Pacific Prime has been selected as the recipient of AXA’s Top…
SINGAPORE - Media OutReach Newswire - 17 May 2024 - MoneyHero Limited (NASDAQ: MNY) ("MoneyHero"…
HONG KONG SAR - Media OutReach Newswire - 17 May 2024 - Sahm Capital, the…
OPENSTREAM HOLDINGS’ subsidiaries, Open Stream and Neutral will strengthen Accenture’s cloud, AI, smart logistics, retail…
SHANGHAI, CHINA - Media OutReach Newswire - 17 May 2024 - The Asia Pacific Enterprise…